Synthetic resins or natural rubbers -- part of the class 520 ser – Synthetic resins – Mixing of two or more solid polymers; mixing of solid...
Reexamination Certificate
1999-09-03
2001-03-20
Rotman, Alan L. (Department: 1612)
Synthetic resins or natural rubbers -- part of the class 520 ser
Synthetic resins
Mixing of two or more solid polymers; mixing of solid...
C525S379000, C526S336000, C546S044000
Reexamination Certificate
active
06204337
ABSTRACT:
FIELD OF THE INVENTION
This invention relates to a polymeric alkylating reagent and its use in alkylation reactions. In a particular embodiment, this invention relates to a methylation resin and its use in a novel method for synthesizing codeine from morphine.
BACKGROUND
Codeine is widely used as both an analgesic and antitussive drug. Codeine occurs naturally in opium to the extent of 0.3% to 4% depending on the source. Codeine is the methyl ether derivative of morphine, another naturally occurring opiate alkaloid. Morphine is present in opium in the range of 9% to 17% by weight. Although morphine is more abundant and a more potent analgesic drug than codeine, the market demand for codeine far exceeds that for morphine.
Codeine is generally prepared by methylating morphine. A trimethylanilinium salt is generally used as the methylating reagent with the counter anion being ethoxide, chloride or hydroxide. The reaction is generally run in toluene or xylene, and when the counter anion is chloride the reaction must be run in the presence of an organic base, such as sodium ethoxide, to remove the proton from the phenoxy group of morphine. Morphine is usually first dissolved in absolute ethanol and then added to the solution of the methylating reagent in a hydrocarbon solvent. Ethanol is distilled out during the reaction.
The prior art processes require the separation of codeine from the side product of the reaction, N,N-dimethylaniline, which is highly toxic and has been reported to be carcinogenic. This methylating reagent is generally not recycled or reused which increases the cost of the procedure and results in environmental concerns. In addition, both morphine and the organic solvents must be anhydrous which further increases the cost of the process. Both the reaction temperature and the ratio of the reactants also have to be strictly controlled in order to produce high quality codeine in good yield. The prior art processes also consume relatively large amounts of various solvents which are difficult to recycle. Finally, the prior art processes require, at the end of the reaction, that any unreacted morphine be removed from the codeine product.
SUMMARY OF THE INVENTION
The present invention addresses the problems and deficiencies of prior methods to synthesize codeine. In one embodiment the invention relates to a methylation resin comprising methyl(dialkyl)anilinium salts or methyl(diaryl)anilinium salts covalently bonded to the resin. The methylation resin is used in the solid-phase synthesis of codeine from morphine. Accordingly, another embodiment of the invention provides a process for methylating morphine to form codeine by loading morphine onto a methylation resin having methyl(dialkyl)anilinium salts or methyl(diaryl)anilinium salts covalently bonded to the resin; contacting the loaded resin with sufficient hydrocarbon solvent to cover the loaded resin; and heating the loaded resin in the hydrocarbon solvent under sufficient conditions to form codeine. The methylating resin may be used to methylate phenolic moieties on other compounds and to esterify compounds containing carboxylic acid moieties.
REFERENCES:
patent: 2874132 (1959-02-01), Riener
patent: 3817878 (1974-06-01), Clemens et al.
patent: 4130515 (1978-12-01), Bornstein
patent: 4207398 (1980-06-01), Riener
patent: 4284758 (1981-08-01), North
patent: 4285758 (1981-08-01), Clausen et al.
patent: 4300898 (1981-11-01), North
patent: 4345063 (1982-08-01), North
patent: 4764615 (1988-08-01), Ayyangar et al.
patent: 5670550 (1997-09-01), Jarvinen et al.
patent: 5981750 (1999-11-01), Corcoran et al.
Chemical Abstracts, vol. 93, (11), abst. No. 114,776h, Sep. 15,1980.
Chemical Abstracts, vol. 109, (5), abst. No. 38,019v, Aug. 1, 1988.
Chemical Abstracts, vol. 112, (21), abst. No. 198,876n, May 21, 1990.
Aldrich, Catalogue of Fine Chemicals, p. 50, 1990.*
Sigma Catalogue of Biochemicals, Organic Compounds For Research and Diagnostic Reagents, p. 8, 1991.
Corcoran Robert C.
Ma Junning
Morgan & Lewis & Bockius, LLP
Rotman Alan L.
The Board of Regents of the University and Community College Sys
LandOfFree
Solid-phase synthesis of codeine from morphine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Solid-phase synthesis of codeine from morphine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Solid-phase synthesis of codeine from morphine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2543219